Influence of Lifestyle Modification in Renal Transplant Recipients With Postprandial Hyperglycemia
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Lifestyle modification is recommended as first-line therapy to manage new-onset diabetes after transplantation (NODAT) and impaired glucose tolerance (IGT). No data currently demonstrate the efficacy of this approach specifically for transplant recipients. This study aimed to assess the benefit of intensive lifestyle modification in this high-risk group and to contrast this with the natural evolution of glucose metabolism after transplantation. METHODS: Baseline oral glucose tolerance test (OGTT) stratified 115 patients into two groups. Group 1 had glucose intolerance, IGT (n=28) and NODAT (n=8), and received intensive lifestyle modification (dietician referral, exercise program, weight loss advice). Group 2 had normal glucose tolerance (n=79) and received lifestyle modification leaflets. Both groups had follow-up OGTT after 6 months to assess change in glycemic status. RESULTS: Excluding all patients who received steroid weaning or withdrawal as part of their management, 111 patients were included in the analysis. Lifestyle modification in group 1 resulted in 15% improvement in 2-hr postprandial glucose versus 12% deterioration in group 2. In group 1, 44% (n=11) of IGT patients developed normal glucose tolerance, whereas only 4% (n=1) developed NODAT. Fifty-eight percent (n=4) of NODAT patients showed improvement (29% to IGT and 29% to normal). Glucose metabolism deteriorated in group 2 with 14% (n=10) developing IGT and 3% (n=2) developing NODAT. CONCLUSIONS: Glucose metabolism can deteriorate in transplant recipients despite passive lifestyle modification advice. This study shows active lifestyle modification benefits high-risk transplant recipients with glucose intolerance and should be aggressively pursued.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Presentation may range from mild hyperglycemia to frank DM, ranging from 1% to 6%.1606,1607”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1606]
Citations
Cites
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“(20) showed how the cumulative incidence of diabetes in a lifestyle intervention group was 11% compared with 23% in a TABLE 3.”
ResultPan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
Boulé, N. G., Haddad, E., Kenny, G. P., Wells, G. A., & Sigal, R. J. (2001) · JAMA · doi:10.1001/jama.286.10.1218 · Cited by 1,889 · cited 2×
“(38) who conducted a meta-analysis of 14 controlled clinical trials assessing the effects of exercise on glycemic control and body mass in type 2 diabetics.”
BackgroundLindström, J., Ilanne-Parikka, P., Peltonen, M., Aunola, S., Eriksson, J. G., Hemiö, K., Hämäläinen, H., Härkönen, P., Keinänen-Kiukaanniemi, S., Laakso, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69701-8 · Cited by 1,799
(1999) · The Lancet · doi:10.1016/s0140-6736(98)12131-1 · Cited by 1,313
Borch‐Johnsen, K., Neil, A., Balkau, B., Larsen, S. H., Nissinen, A. E. T., Pekkanen, J., Keinanen-Kiukaanniemi, S. M., Hiltunen, L. A., Kivelä, S., Tuomilehto, J. O., et al. (1999) · The Lancet · Cited by 1,272
Tominaga, M., Eguchi, H., Manaka, H., Igarashi, K., Kato, T., & Sekikawa, A. (1999) · Diabetes Care · doi:10.2337/diacare.22.6.920 · Cited by 1,165
Writing committee, Unwin, N., Shaw, J., Zimmet, P., & Alberti, K. G. M. M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00835.x · Cited by 1,108 · cited 1×
“In the general population, studies have shown lifestyle modification can have beneficial effects on the diabetogenicity of an individual, especially in patients with IGT who are at high risk of developing diabetes (5, 10, 13, 16).”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 2×
“Insulin resistance is a pathological state in which target cells fail to respond to ordinary levels of circulating insulin (35, 36).”
BackgroundPhysical Activity/Exercise and Type 2 Diabetes
Sigal, R. J., Kenny, G. P., Wasserman, D. H., & Castaneda-Sceppa, C. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2518 · Cited by 763 · cited 2×
“Suggested mechanisms include increased postreceptor insulin signaling, increased glucose transporter and messenger RNA and increased activity of glycogen synthase and hexokinase (39).”
Background
Research works printed but not linked: 1
- 2006, Standards of medical care in diabetes—2006., Diabetes Care, 29, S4
Cited by
Items 101–144 of 144
Long-term Challenges After Solid Organ Transplantation
Legendre, C. M., Viebahn, R., Fehrman‐Ekholm, I., Masnou, N., Berenguer, M., Potena, L., Wennberg, L. M., O’Grady, J., Epailly, É., Diekmann, F., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002316 · Cited by 5
[Assessment of lipid profiles and bone mineral density in renal transplant patients].
Castillo, R. F., Gallegos, R. F., Amaro, M. P. P., & de la Rosa, R. J. E. (2015) · PubMed · doi:10.3305/nh.2015.31.6.8719 · Cited by 4
Renal rehabilitation: the benefits, barriers and exercise options
Castle, E. M., Koufaki, P., Clark, R., Lindup, H., Mercer, T. H., Macdougall, I. C., & Greenwood, S. A. (2014) · Journal of Renal Nursing · doi:10.12968/jorn.2014.6.1.29 · Cited by 4
von Düring, M. E., Jenssen, T. G., Bollerslev, J., Godang, K., Hartmann, A., & Åsberg, A. (2018) · Clinical Transplantation · doi:10.1111/ctr.13341 · Cited by 4
Sanyal, D., Biswas, M., & Chaudhari, N. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.11.019 · Cited by 4
Developing a Healthy Lifestyle Program for Recent Kidney Transplant Recipients
Gibson, C., Gupta, A., Naik, A. S., Sullivan, D. K., Doshi, M. D., Backes, J., Harvey, S. P., Lee, J., Mount, R. R., Valentine, H., et al. (2023) · Progress in Transplantation · doi:10.1177/15269248231189878 · Cited by 7
Wissing, K. M., Meyer, V. D., & Pipeleers, L. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.08.013 · Cited by 4
Treating posttransplantation diabetes mellitus
Pérez‐Sáez, M. J., Marín-Casino, M., & Pascual, J. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1039983 · Cited by 3
Klaassen, G., Corpeleijn, E., Deetman, N. P. E., Navis, G., Bakker, S. J. L., & Zelle, D. M. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000717 · Cited by 3
“Increased liver enzymes in RTR, particularly when coexisting with increased waist circumference, should be an incentive to target lifestyle factors, such as physical activity and dietary habits to prevent or even reverse hepatic fat deposition.(32) Indeed, lifestyle interventions leading to a reduction in bodyweight a…”
BackgroundAcosta-Gualandri, A., Blydt‐Hansen, T. D., Islam, N., & Amed, S. (2021) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2021.05.004 · Cited by 3
Febles, R. M., Miranda, D. M., Perera, C. C., Martin, L. D., Rodríguez‐Rodríguez, A. E., Martín, A. R. G., Báez, D. J. S., & Porrini, E. (2023) · The Nephron journals/Nephron journals · doi:10.1159/000531921 · Cited by 3
“Of relevance, 2 studies were speci fi cally designed in patients with prediabetes or PTDM [50, 55].”
BackgroundInfluential[Assessment of nutritional status in renal transplant patients during 5 years of follow-up].
Castillo, R. F., Gallegos, R. F., Álvarez‐Serrano, M. A., Negrillo, A. M. N., Navarro‐Pérez, C. F., & Alfonso, A. I. Q. (2014) · PubMed · doi:10.3305/nh.2014.30.5.7696 · Cited by 3
Sarabhai, T., Mathew, A., Rashidi‐Alavijeh, J., Willuweit, K., Gallinat, A., & Führer, D. (2026) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.m2026.0019 · Cited by 2
Fung, S. K. S., Chau, K., & Chow, K. M. (2019) · Nephrology · doi:10.1111/nep.13502 · Cited by 2
“Results on strategy of dietitian education, graded exercise program and advice on weight loss has remain limited, but provide early evidence to attenuate or reverse the progression of glycaemic dysregulation after transplant.(91)”
BackgroundSerna-Higuita, L. M., López, M. C. I., Hernández-Herrera, G., Serna-Campuzano, A. M., Nieto‐Ríos, J. F., Heyne, N., & Guthoff, M. (2023) · Transplantation Direct · doi:10.1097/txd.0000000000001558 · Cited by 2
“46 Bariatric surgery before kidney transplantation may also be considered for high-risk patients.”
BackgroundGraňák, K., VNUCAK, M. B. M., & Dedinská, I. (2024) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2024_38 · Cited by 2
Management of Posttransplantation Diabetes Mellitus (PTDM)
Soo, B., & Moon, J. H. (2011) · Korean Journal of Transplantation · doi:10.4285/jkstn.2011.25.1.8 · Cited by 2
“실제 이식 후 환자를 대상으로 생활습관교정의 효과를 입증한 연구에 따르면 신장이식 후 생활습관교정에 의해 이식 후 당뇨병의 발생이 감소하였으며 이식과 관련된 혈당상 승이 감소하였다(51).”
Castillo, R. F., Ríos, M. D. C. G., Amaro, P. P., & García, I. G. (2014) · International Journal of Clinical Practice · doi:10.1111/ijcp.12465 · Cited by 2
Exercise and Prediabetes after Renal Transplantation (EXPRED): Protocol Description
Febles, R. M., Mena, N. N., Rodríguez‐Rodríguez, A. E., Martin, L. D., Rinne, F. G., Miranda, D. M., Rinne, A. G., González, A. M. Á., Tamajón, L. P., Sørensen, C. A., et al. (2020) · The Nephron journals/Nephron journals · doi:10.1159/000511320 · Cited by 2
Nutrition in intestinal transplantation: centre stage or supporting act?
Oosterwyck, A. V., Lauwers, N., Pauwels, N., & Vanuytsel, T. (2022) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000901 · Cited by 2
“transplant recipients with glucose intolerance showed that this had a positive effect with regard to glucose metabolism [59].”
BackgroundCentenaro, A., Pedrollo, E. F., Nicoletto, B. B., Manfro, R. C., Gonçalves, L. F. S., Leitão, C. B., & Souza, G. C. (2017) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2017.08.007 · Cited by 1
Mediterranean Diet: How Useful is it in Kidney Transplant Patients?
Afşar, B., Afşar, R. E., & Lentine, K. L. (2026) · Current Transplantation Reports · doi:10.1007/s40472-026-00508-9 · Cited by 1
Madziarska, K., Hap, K., Mazanowska, O., & Sutkowska, E. (2021) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.8311 · Cited by 1
COMPLICACIONES METABÓLICAS TRAS EL TRASPLANTE RENAL
Díaz, G. B., & Acosta, M. B. (2014) · Revista Cubana de Alimentación y Nutrición · Cited by 5
Complicaciones metabólicas tras el trasplante renal
Bayés, B. (2009) · Nefrología · Cited by 1
Castillo, R. F. (2016) · Nutrición Hospitalaria · doi:10.20960/nh.394 · Cited by 1
Diabetes mellitus vor und nach Nierentransplantation: Grundlagen, Prävention und Therapie
Guthoff, M. (2018) · Dialyse aktuell · doi:10.1055/a-0629-1963 · Cited by 1
“Insgesamt liegt die Prävalenz von Störungen im Glukosemetabolismus nach Nierentransplantation bei über 50 % und stellt somit ein entscheidendes Problem dar.”
BackgroundInfluentialDiabetes in Kidney Transplant Recipients
Dhital, S. M. (2018) · Springer eBooks · doi:10.1007/978-3-030-00132-2_10 · Cited by 1
Cardiovascular Disease and Preventive Healthcare after Organ Transplantation
Pastan, S. O., & Gupta, D. (2014) · Wiley eBooks · doi:10.1002/9781118873434.ch88
New-onset diabetes after transplantation: focus on strategies to reduce risk
Sharif, A. (2011) · Diabetes Management · doi:10.2217/dmt.11.10
Self-citationLifestyle, the next target for intervention in renal transplant recipients
Zelle, D. M. (2013) · University of Groningen research database (University of Groningen / Centre for Information Technology)
NAUJAI IŠSIVYSTANTIS CUKRINIS DIABETAS PO INKSTŲ TRANSPLANTACIJOS
Alavočiūtė, U., Kantauskaitė, M., & Miglinas, M. (2015) · Medicinos teorija ir praktika · doi:10.15591/mtp.2015.107
Kidney Transplantation and Diabetic Nephropathy
Kers, J., & Bemelman, F. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_26
Knowledge and Attitude of Nurses toward Post-Liver Transplantation Diabetes Mellitus
Yoo, J. A., & Park, J. Y. (2020) · Daehan imsang geon-gang jeungjin hakoeji/Daehan imsang geon'gang jeungjin haghoeji · doi:10.15384/kjhp.2020.20.1.16
Bonnet, J., Grey, D., Agbanglanon, A., Galibert, L., Rakotoarivony, D., Vidal, M., Gourc, C., Attalin, V., & Avignon, A. (2020) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2020.10.003
ANTíGENOS HLA ESTÃO ASSOCIADOS A RISCO DE DIABETES MELLITUS PÓS-TRANSPLANTE?
de Lucena, D. D., de Marco, R., de Sá, J. R., Pestana, J. O. M., Gerbase‐DeLima, M., & Rangel, É. B. (2021) · Brazilian Journal of Transplantation · doi:10.53855/bjt.v24i1.2
Sharif, A. (2022) · Transplantation · doi:10.1097/tp.0000000000004198
Self-citationPost-Transplantations-Diabetes mellitus: Häufige Komplikation nach Transplantation
Ott, U. (2023) · Nephrologie aktuell · doi:10.1055/a-2055-3728
Management of new onset dysglycemia in transplant recipients
Sharif, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85732-1.00045-1
Self-citationSchlosser, M. (2024) · Nephrologie aktuell · doi:10.1055/a-2307-2703
Estudio de las alteraciones del metabolismo lipídico en el paciente trasplantado renal
Castillo, R. F., & Gallegos, R. F. (2012)
Evaluation and Management of Transplant-Associated Hyperglycemia
Bloom, R. D., & Moussallem, C. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0342-9_21
Yeh, H., Cc, L., Li, Y.-R., Yen, C.-L., Lee, C.-C., Chen, J.-S., Chen, K.-H., Tian, Y.-C., Liu, P.-H., & Hsiao, C.-C. (2020) · Figshare · doi:10.6084/m9.figshare.12211415
Nutritional strategies in kidney transplantation: optimising outcomes beyond surgery
Caldiroli, L., Molinari, P., Vettoretti, S., Regalia, A. L., Verdesca, S., Castellano, G., Gallieni, M. A., & Alfieri, C. (2026) · Transplant International · doi:10.3389/ti.2026.16322
Metadata
- Authors
- Sharif, A., Moore, R., & Baboolal, K.
- Affiliations
- University Hospital of Wales (GB)
- Corresponding author
- Sharif, Adnan
- Venue
- Transplantation
- Published
- 2008-02-15
- Volume
- 85
- Issue
- 3
- Pages
- 353-358
- ISSN
- 0041-1337 (ISSN-L)
- OpenAlex
- W1968567860
- Cited by
- 144
- References
- 39
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 7 · 2023: 5 · 2022: 7 · 2021: 13 · 2020: 14 · 2019: 5 · 2018: 14 · 2017: 5 · 2016: 7 · 2015: 14 · 2014: 13 · 2013: 8 · 2012: 7
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Transplantation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- lifestyle modification, kidney transplant recipients, postprandial hyperglycemia, post-transplant diabetes mellitus, impaired glucose tolerance, oral glucose tolerance test, exercise program, dietician referral, weight loss advice
- MeSH terms
- Female, Humans, Hyperglycemia, Life Style, Male, Middle Aged, Kidney Transplantation, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.